DELSTRIGO

NDC 0006-5007 · Merck Sharp & Dohme LLC

Generic namedoravirine, lamivudine, and tenofovir disoproxil fumarate

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE

Strength100; 300; 300 mg/1; mg/1; mg/1

Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]

Marketing categoryNDA

Packages

0006-5007-01 — 30 TABLET, FILM COATED in 1 BOTTLE (0006-5007-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0006-3069 — doravirine, 0006-5092 — Doravirine, Islatravir, 0093-5234 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 0093-7704 — Emtricitabine and Tenofovir Disoproxil Fumarate, 0378-5440 — Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate, 0904-6583 — lamivudine, 0904-6821 — tenofovir disoproxil fumarate, 0904-7172 — Emtricitabine and Tenofovir Disoproxil Fumarate, 16714-534 — Emtricitabine and tenofovir disoproxil fumarate, 16714-820 — Tenofovir Disoproxil Fumarate, 31722-001 — lamivudine, 31722-506 — LAMIVUDINE and ZIDOVUDINE, 31722-535 — Tenofovir Disoproxil Fumarate, 31722-560 — Emtricitabine and tenofovir disoproxil fumarate, 31722-736 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 31722-739 — Lamivudine and Zidovudine, 31722-752 — Lamivudine, 31722-753 — Lamivudine, 31722-754 — Lamivudine, 31722-838 — ABACAVIR and LAMIVUDINE, +120 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels